Tags
- 1C
- 22nd century
- 3
- 6
- A
- A10
- Abnormal
- Acceptance
- Accession
- Acid
- Acting
- Activate
- Activation
- Active site
- Acts
- Adenosine
- Adenosine triphosphate
- Adhesion
- AKT1
- Akt/PKB signaling pathway
- Al Cell
- Al Med
- Almost
- Al Nat
- Alvocidib
- Amino Acid
- Amplification
- An
- Apoptosis
- Application
- Approval
- Approved
- Approved drug
- ATP
- Balanced line
- Base pair
- BIND
- Binding
- Biological membrane
- Block
- Body
- Breast
- Breast cancer
- Breast cancer management
- C2
- C2 domain
- Cancer
- Cancer Cell
- Cancer research
- Canonical
- Carcinogenesis
- Carcinoma
- Carries
- Cascade
- Cause
- Causes
- Cell
- Cell Cycle
- Cell death
- Cell division
- Cell growth
- Cell membrane
- Cell movement
- Cells
- Cell signaling
- Cell survival
- Cellular
- Cellular activities
- Cellular respiration
- Chain
- Chains
- Chemical
- Chen
- Chromosome
- Chu
- Claim
- Claims
- Coactivator
- Code
- Come
- Companion
- Complex
- Composed
- Compound
- Concentration
- Constitutive
- Containment
- Copy
- Cowden
- Cowden syndrome
- Cross-reference
- Crystallography
- Cycle
- Cyclin
- Cyclin D1
- Cyclin-dependent kinase
- Cytoplasm
- D1
- Damage
- Death
- Defective
- Demonstration
- DēP
- Dephosphorylation
- DEPTOR
- Determined
- Development
- Diagnosis
- Die
- Disclosed
- Disclosure
- Disease
- Division
- DNA
- DNA damage
- D.O.E.
- Domain
- Downstream
- Drive
- Drives
- Drug
- Drugs
- Dual
- Effector
- EGFR
- Endometrial cancer
- Endometrium
- Enhance
- ENTPD5
- Enzyme
- Enzyme assay
- Epidermal growth factor
- Epidermis
- Epistasis
- Erlotinib
- Establishment
- E.T.
- Everolimus
- Evidence
- Exhibit
- Exhibition
- Expression
- Extent
- Facilitation
- Factor
- FIGS
- Filamin
- Filing
- FLNA
- Formation
- Four
- FOX proteins
- Frequency
- Gene Act
- Gene Steck
- Genetic
- Glioblastoma
- Glycogen
- Glycogen synthase
- Glycogen synthase kinase
- Greater
- Growth
- Growth factor
- Growth factor receptor
- GSK-3
- Hallmark
- High frequency
- Homology
- Host
- Humans
- Id
- If
- Impact
- Inactivation
- Include
- Incorporated
- Information Technology Act, 2000
- Inhibition
- Inhibitor
- Inhibitory postsynaptic potential
- Inositol
- Insensitive
- Interaction
- Interactions
- Intracellular
- Invention
- Involve
- KDA
- Kidney
- Kinase
- Knockout
- Known
- Ko
- Large number
- latest
- Launch Complex 2
- Levels
- Ligand
- Lipid
- Lipid bilayer
- Loss
- Lost One
- Lung cancer
- Lung cancer treatment
- Make-Up
- Mammalian
- Manner
- Map
- MAPK1
- Mechanistic target of rapamycin
- Mediated
- Mediation
- Medical Science Monitor
- Med Sci
- MEK
- Melanoma
- Membrane
- Men
- Messenger
- Metabolism
- Method
- Micrometre
- MicroRNA
- Migration
- MIRN21
- Mitogen-activated protein kinase kinase
- MLST8
- Models
- Molecule
- Molecules
- Monit
- Most
- Mouse
- Movement
- MTORC1
- MTORC2
- Mutation
- Mutations
- -Naloxone
- Nature
- Nature Genetics
- Negative
- Neoplasm
- No
- Nuclear
- Nucleotide
- Nucleotide triphosphate
- Nucleus
- Number
- On and Off
- Oncogene
- Oncomir
- Operation Undergo
- P27
- Pain
- Pair
- PAIRS Foundation
- Particular
- Partner
- Patent
- Pathway
- Pentapeptide repeat
- Peroxisome
- Peroxisome proliferator-activated receptor gamma
- Pharmacophore
- Phase
- -phosphatase
- Phosphate
- Phosphatidylinositol
- Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase
- Phosphatidylinositol 4,5-bisphosphate
- Phosphatidylinositol -trisphosphate
- Phosphoinositide 3-kinase
- Phospholipid
- Phosphorylation
- Phosphorylation cascade
- PI3K/AKT/mTOR pathway
- PIP2
- Pipeline
- PKB
- Playing
- Polyphosphate
- Position
- Positions
- PPA
- PPARGC1A
- Prevention
- Priority
- Product
- Production
- Programmed
- Programmed cell death
- Proliferation
- Propagation
- Prostate
- Prostate cancer
- Protein
- Protein kinase
- Protein kinase B
- Protein phosphatase
- Protein phosphorylation
- Protein–protein interaction
- Proteins
- Protein serine/threonine phosphatase
- Protein tyrosine phosphatase
- Pseudonym
- PTEN
- Pyrophosphate
- Rapidly
- Reaction
- Receptor
- Receptor tyrosine kinase
- Recognized
- Reduction
- Regulate
- Regulation
- Regulator
- Relate
- Remove
- Renal cell carcinoma
- Research
- Researcher
- Residue
- Return to Cookie Mountain
- Reverse
- RICTOR
- Ring
- Salt
- SCI
- Sclerosis
- Search
- SEC13
- Selumetinib
- SEQ
- Serine/threonine-specific protein kinase
- Side chain
- Signal
- Signaling
- Signals
- Signal transduction
- Sirolimus
- Six
- SKP2
- Small cell
- Small number
- Solved
- Some
- Specificity
- S phase
- Sp/KLF family
- Steck
- Sterol regulatory element-binding protein 1
- Structural similarity
- Structure
- Substrate
- Suppressor
- Suppressors
- Surface
- Surrounding
- Survival
- Switch
- Switched
- Syndrome
- Synthase
- Target
- Target protein
- Targets
- TBC1D4
- Technical
- Temsirolimus
- Ten
- Tensin
- The body
- The Breast
- The Cell
- Therapy
- The Signal
- The time
- Threonine
- Thyroid
- Tissue
- Train
- Transduction
- Transmitter
- Trastuzumab
- Treatment of cancer
- TSC2
- Tuber
- Tuberous sclerosis
- Tuberous sclerosis protein
- Tumor
- Tumor development
- Tumor growth
- Tumor suppressor gene
- Turning
- Tyrosine
- Tyrosine kinase
- Uncontrolled
- Uncontrolled cell growth
- UniProt
- United States patent law
- Uterus
- Various Positions
- Via
- Vital
- When
- X-Ray
- X-ray crystallography